India Invests $1.2B in Homegrown Medicine Revolution
India just committed $1.2 billion to develop cutting-edge biologic medicines at home, aiming to treat cancer, diabetes, and autoimmune diseases without relying on imports. The five-year Biopharma Shakti program could transform how the nation tackles its biggest health challenges.














